A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
Clinical trial NCT03602755 · COMPLETED
Trial details
- NCT number
- NCT03602755
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-19
- Primary completion
- 2019-01-18
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.